Dr Andy Richards

Chairman of Arecor, Congenica, Abcodia, and Babraham Bioscience Technologies Ltd (BBT) at Babraham Research Campus

Share
Serial Biotechnology Entrepreneur and Business Angel

Andy Richards is an entrepreneur and investor with an established track record in founding and scaling up innovative Biotech and Healthtech companies in the UK. He is currently Chairman of Arecor, Congenica, Abcodia, and Babraham Bioscience Technologies Ltd (BBT) at the Babraham Research Campus and is a Director of Ieso Digital Health, Silence Therapeutics plc, Cancer Research Technology (commercial arm of CR-UK), and Sensiia. He is an advisor to several investment funds including Cambridge Innovation Capital and the UCL Technology Fund and was, until recently, a director of Cambridge University Hospitals NHS Foundation Trust.

Andy is a Cambridge Graduate with a PhD in Chemistry and an early career spanning positions with ICI (now AstraZeneca) and PA Technology. He was a founder and executive director of Chiroscience plc until its merger with Celltech in 1999 and since that time he has founded, invested in and helped to scale more than 25 innovative ventures including companies such as Vectura, Arakis, Cambridge Biotechnology Ltd and Geneservice. Andy is also a founder member of the Cambridge Angels. He received a CBE for services to life-science investment in 2015.

  • 11 June 2020, 9:30am

    CSaP Annual Conference Seminar Series 2020

    This year instead of holding a one-day annual conference in London, we will be delivering a series of virtual seminars in May and June on topics that CSaP and our network have worked on over the past year

  • 13 March 2018, 4pm

    Goal posts or judging panels?

    A policy workshop to explore the challenges of performance measurement for government in the context of innovation, life sciences and UK plc.